Biblio

Found 23 results
Filters: Author is Wareham, Nick  [Clear All Filters]
2012
Grote VA, Rohrmann S, Dossus L, Nieters A, Halkjaer J, Tjønneland A, Overvad K, Stegger J, Chabbert-Buffet N, Boutron-Ruault M-C et al..  2012.  The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort.. Int J Cancer. 130(10):2428-37.
Grote VA, Nieters A, Kaaks R, Tjønneland A, Roswall N, Overvad K, Nielsen M SR, Clavel-Chapelon F, Boutron-Ruault M C, Racine A et al..  2012.  The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort.. Cancer Epidemiol Biomarkers Prev. 21(4):619-28.
Murphy N, Norat T, Ferrari P, Jenab M, Bueno-de-Mesquita B, Skeie G, Dahm CC, Overvad K, Olsen A, Tjønneland A et al..  2012.  Dietary fibre intake and risks of cancers of the colon and rectum in the European prospective investigation into cancer and nutrition (EPIC).. PLoS One. 7(6):e39361.
Michaud DS, Izard J, Wilhelm-Benartzi CS, You D-H, Grote VA, Tjønneland A, Dahm CC, Overvad K, Jenab M, Fedirko V et al..  2012.  Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.. Gut.
Fedirko V, Riboli E, Tjønneland A, Ferrari P, Olsen A, Bueno-de-Mesquita BH, van Duijnhoven FJB, Norat T, Jansen EHJM, Dahm CC et al..  2012.  Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.. Cancer Epidemiol Biomarkers Prev. 21(4):582-93.
Travis RC, Allen NE, Appleby PN, Price A, Kaaks R, Chang-Claude J, Boeing H, Aleksandrova K, Tjønneland A, Johnsen N F et al..  2012.  Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC.. Cancer Causes Control. 23(7):1163-71.
Gallo V, Mackenbach JP, Ezzati M, Menvielle G, Kunst AE, Rohrmann S, Kaaks R, Teucher B, Boeing H, Bergmann MM et al..  2012.  Social inequalities and mortality in Europe--results from a large multi-national cohort.. PLoS One. 7(7):e39013.
Caboux E, Lallemand C, Ferro G, Hémon B, Mendy M, Biessy C, Sims M, Wareham N, Britten A, Boland A et al..  2012.  Sources of pre-analytical variations in yield of DNA extracted from blood samples: analysis of 50,000 DNA samples in EPIC.. PLoS One. 7(7):e39821.
Aleksandrova K, Boeing H, Jenab M, Bueno-de-Mesquita BH, Jansen E, van Duijnhoven FJB, Fedirko V, Rinaldi S, Romieu I, Riboli E et al..  2012.  Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study.. Carcinogenesis. 33(6):1211-8.
2011
Schütze M, Boeing H, Pischon T, Rehm J, Kehoe T, Gmel G, Olsen A, Tjønneland AM, Dahm CC, Overvad K et al..  2011.  Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study.. BMJ. 342:d1584.
Michaud DS, Bové G, Gallo V, Schlehofer B, Tjønneland A, Olsen A, Overvad K, Dahm CC, Teucher B, Boeing H et al..  2011.  Anthropometric measures, physical activity, and risk of glioma and meningioma in a large prospective cohort study.. Cancer Prev Res (Phila). 4(9):1385-92.
Timofeeva MN, McKay JD, Smith G D, Johansson M, Byrnes GB, Chabrier A, Relton C, Ueland P M, Vollset S E, Midttun Ø et al..  2011.  Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC.. Cancer Epidemiol Biomarkers Prev. 20(10):2250-61.
Franceschi S, Lise M, Trépo C, Berthillon P, Chuang S-C, Nieters A, Travis RC, Vermeulen R, Overvad K, Tjønneland A et al..  2011.  Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC).. Cancer Epidemiol Biomarkers Prev. 20(1):208-14.
van Veldhoven CM, Khan AE, Teucher B, Rohrmann S, Raaschou-Nielsen O, Tjønneland A, Overvad K, Vigl M, Boeing H, Benetou V et al..  2011.  Physical activity and lymphoid neoplasms in the European Prospective Investigation into Cancer and nutrition (EPIC).. Eur J Cancer. 47(5):748-60.
Chajès V, Jenab M, Romieu I, Ferrari P, Dahm CC, Overvad K, Egeberg R, Tjønneland A, Clavel-Chapelon F, Boutron-Ruault M-C et al..  2011.  Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).. Am J Clin Nutr. 94(5):1304-13.
Baltar V T, Xun WW, Chuang S-C, Relton C, Ueland P M, Vollset S E, Midttun Ø, Johansson M, Slimani N, Jenab M et al..  2011.  Smoking, secondhand smoke, and cotinine levels in a subset of EPIC cohort.. Cancer Epidemiol Biomarkers Prev. 20(5):869-75.